14-day Premium Trial Subscription Try For FreeGet Free

Range Low Price High Price Comment
30 days $55.25 $109.96 Monday, 27th Nov 2023 SRPT stock ended at $82.58. This is 0.35% less than the trading day before Friday, 24th Nov 2023. During the day the stock fluctuated 2.94% from a day low at $81.64 to a day high of $84.04.
90 days $55.25 $125.00
52 weeks $55.25 $159.89

Historical Sarepta Therapeutics prices

Date Open High Low Close Volume
2023-11-27 $82.50 $84.04 $81.64 $82.58 646 125
2023-11-24 $83.83 $84.23 $82.28 $82.87 394 702
2023-11-22 $84.42 $85.21 $82.06 $83.77 603 142
2023-11-21 $85.03 $85.40 $83.42 $84.08 995 335
2023-11-20 $83.00 $85.94 $82.62 $83.06 1 276 550
2023-11-17 $82.98 $85.50 $82.77 $83.15 1 387 956
2023-11-16 $83.08 $83.43 $81.18 $82.98 1 407 391
2023-11-15 $81.77 $84.71 $81.47 $83.76 1 143 631
2023-11-14 $81.93 $82.56 $80.68 $82.50 1 654 634
2023-11-13 $79.74 $80.30 $76.61 $79.67 882 454
2023-11-10 $78.81 $79.66 $76.26 $79.45 1 269 756
2023-11-09 $79.88 $80.26 $75.88 $79.15 2 037 121
2023-11-08 $82.93 $83.47 $80.40 $80.69 1 074 185
2023-11-07 $80.62 $84.19 $80.62 $82.93 2 151 784
2023-11-06 $81.50 $83.11 $79.66 $80.10 2 575 264
2023-11-03 $78.42 $81.27 $77.80 $78.01 2 257 808
2023-11-02 $79.43 $82.22 $75.70 $77.76 3 663 648
2023-11-01 $57.63 $76.77 $57.63 $76.52 6 517 699
2023-10-31 $57.63 $68.00 $55.25 $67.31 23 399 522
2023-10-30 $107.95 $109.96 $106.92 $107.65 731 715
2023-10-27 $111.90 $111.90 $106.05 $106.83 917 966
2023-10-26 $107.39 $112.23 $105.92 $111.60 1 081 288
2023-10-25 $112.39 $112.66 $106.52 $107.24 1 094 989
2023-10-24 $111.63 $113.95 $110.72 $113.42 827 314
2023-10-23 $111.00 $113.42 $109.78 $111.40 852 949
Click to get the best stock tips daily for free!

About Sarepta Therapeutics

Sarepta Therapeutics Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of ... SRPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT